Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-25-028226

Options or other derivatives

  • Chief Executive Officer returned 2,385,976 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

SETH SANDESH · Chief Executive Officer

Table II: Derivative

8 lines
Date Transaction Shares Owned after D/I
2025-03-31 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −16,666 0 D
2025-03-31 Returned to the company : show line 2 in the form Stock Option (Right to Buy) −25,000 0 D
2025-03-31 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −33,333 0 D
2025-03-31 Returned to the company : show line 4 in the form Stock Option (Right to Buy) −50,000 0 D
2025-03-31 Returned to the company : show line 5 in the form Stock Option (Right to Buy) −139,062 0 D
2025-03-31 Returned to the company : show line 6 in the form Stock Option (Right to Buy) −310,182 0 D
2025-03-31 Returned to the company : show line 7 in the form Stock Option (Right to Buy) −827,366 0 D
2025-03-31 Returned to the company : show line 8 in the form Stock Option (Right to Buy) −984,367 0 D
Loading xslF345X05/ownership.xml…